??-Blockers for Chronic Heart Failure

Experience accumulated from several large trials strongly suggest that β-blockers should be used for the management of congestive heart failure (CHF). β-Blockade should be added to conventional therapy such as diuretics, ACE inhibitors, and digoxin, as this was the approach used in the major trials. It is appropriate to treat patients with mild, moderate and, when stable, severe CHF. The benefits obtained include improvements in left ventricular function, reductions in symptoms and morbidity, improvement of quality of life, and delay of clinical progression, reflected by a reduced need for hospitalization and a reduction in mortality. β-Blockers are much better tolerated, when used appropriately in selected patients, than was previously supposed.